Caribou Biosciences CRBU
NASDAQ CRBU
$1.22 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Caribou Biosciences (CRBU) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Caribou Biosciences (CRBU) recorded Depreciation & Amortization (CF) of $625,000 in Q2 2026, down 46.4% from $1.17 million a year earlier and down 3.7% from the prior quarter.

Analysis

Caribou Biosciences (CRBU) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

On a TTM basis, Caribou Biosciences' Depreciation & Amortization (CF) came in at $2.59 million as of Jun 30, 2026, down 44.9% year-over-year; for FY2025, it came in at $3.65 million, down 7.2% from FY2024.

  • Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of 32.3% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $3.93 million in FY2024 (+11.4%), $3.53 million in FY2023 (+117.3%), $1.62 million in FY2022 (+64.8%) and $984,000 in FY2021 (+9.3%).
  • The Q2 2026 figure is the lowest quarterly Depreciation & Amortization (CF) since Q2 2023.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined for four consecutive quarters, with an average decline of 5.6% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 250.9% in Q3 2023, against a decline of 46.4% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $649,000 (Q1 2026), $682,000 (Q4 2025) and $631,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Caribou Biosciences 129.31 Mn -387.22 Mn - 625,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 625,000.00
Mar 31, 2026 649,000.00
Dec 31, 2025 682,000.00
Sep 30, 2025 631,000.00
Jun 30, 2025 1.17 Mn
Mar 31, 2025 1.17 Mn
Dec 31, 2024 1.18 Mn
Sep 30, 2024 1.18 Mn
Jun 30, 2024 856,000.00
Mar 31, 2024 710,000.00
Dec 31, 2023 740,000.00
Sep 30, 2023 1.58 Mn
Jun 30, 2023 617,000.00
Mar 31, 2023 589,000.00
Dec 31, 2022 506,000.00
Sep 30, 2022 450,000.00
Jun 30, 2022 358,000.00
Mar 31, 2022 308,000.00
Dec 31, 2021 273,000.00
Sep 30, 2021 260,000.00
API Access

Caribou Biosciences Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CRBU&period=max&api_key=YOUR_API_KEY